At the Forefrontof Fintech.

Wilson Sonsini represented Blockstack in the first-ever offering of a cryptocurrency token to be either qualified or registered under federal securities laws of the U.S. for sale to the public.

Wilson Sonsini Goodrich & Rosati's legacy closely traces the birth and evolution of Silicon Valley.

For more than six decades, Wilson Sonsini has represented the technology pioneers associated with virtually every milestone innovation.

Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.

Read More About Us

Quick Links

Introducing Neuron, a new platform that streamlines, automates, and digitizes the typical legal processes along a start-up’s journey

Neuron Website

Careers

We look for the best and brightest of tomorrow and develop careers from the ground up.

News and Featured Insights

Press Releases

Wilson Sonsini's Litigation Department Continues to Grow as Melissa Mills Joins as a Partner in Los Angeles

Newsletters

The PTAB Review - June 2022

Alerts

FDA Issues Guidance on Importing Drugs from Canada

Leading Matters

Client Highlights

Wilson Sonsini Represents LinkedIn in Its Acquisition of EduBrite

On June 28, 2022, LinkedIn announced that it entered into an agreement to acquire EduBrite, a platform that specializes in creating, hosting, and deploying professional certificates. The acquisition will allow LinkedIn to integrate EduBrite’s rigorous certification assessment engine into the LinkedIn Learning platform which will enable LinkedIn to better test and verify the skills people have to help them grow in their careers and enable them to earn credentials from organizations that they can then showcase on their LinkedIn profile.

Learn More

Client Highlights

Wilson Sonsini Advises Ledger Investing in $75 Million Series B

On June 22, 2022, Ledger Investing, an InsurTech start-up connecting insurance risk with capital, announced that it has raised $75 million in its Series B funding round led by WestCap, with participation from Teachers’ Venture Growth and Intact Ventures, and previous investors SignalFire, MassMutual Ventures, Allegis Capital, and Accel. Wilson Sonsini Goodrich & Rosati represented Ledger Investing in the transaction.

Learn More

Client Highlights

Wilson Sonsini Advises CellPoint on Acquisition by Galapagos

On June 21, 2022, Galapagos, a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines, announced it has signed a definitive agreement for an all-cash acquisition of CellPoint for an upfront payment of €125 million, with additional milestone payments up to €100 million. CellPoint is dedicated to developing CAR-T therapies at the point-of-care, making these therapies more affordable and accessible to patients. Wilson Sonsini Goodrich & Rosati advised CellPoint on the transaction.

Learn More

Client Highlights

Firm Advises Turntide Technologies on $80 Million Fundraise

On June 15, 2022, Turntide Technologies announced that it has secured $80 million in equity funding, valuing the company at over $1 billion. Turntide develops electrification and sustainable operations technologies, which include energy-efficient motors, dramatically reducing carbon emissions and improving energy savings for building operations, agriculture, equipment, and commercial and industrial vehicles. Wilson Sonsini Goodrich & Rosati advised Turntide on the transaction.

Learn More

Client Highlights

Boehringer Ingelheim Signs Option to Acquire Trutino Biosciences

On June 14, 2022, Boehringer Ingelheim, a leading research-driven biopharmaceutical company, announced the signing of an option to acquire Trutino Biosciences Inc., a San Diego-based pre-clinical stage biotech company dedicated to the discovery and development of next-generation cytokine therapies to treat immuno-oncology and autoimmune diseases. Wilson Sonsini Goodrich & Rosati advised Trutino Biosciences in the transaction.

Learn More

Client Highlights

Wilson Sonsini Advises OhmConnect on $55 Million Series D

On June 9, 2022, OhmConnect, the leading provider of residential energy flexibility, announced it has raised $55 million in its Series D funding round led by ClearSky, Sidewalk Infrastructure Partners (SIP), and TELUS Ventures. Wilson Sonsini Goodrich & Rosati represented OhmConnect in the transaction.

Learn More

See More Leading Matters

The Life Sciences Report – June 2022

This latest issue features articles on the firm’s new Boulder office and recent Gateway to Colorado VC roadshow, a collaboration between Deloitte’s Center for Health Solutions and MedTech Innovator to evaluate trends across the medical technology start-up landscape, and life sciences venture financings in which clients participated across the first half and second halves of 2021. It also includes an update on the priority fight between UC and the Broad Institute over CRISPR gene editing patents, articles addressing patented inventions under the patent safe harbor of Section 271(e)(1) and the firm’s partnership with Bakar Labs, and a summary of select recent life sciences client highlights and upcoming events.